The Mel-MBG/SA hydrogel further provides a mixed system with sustained Mel release to alleviate IL-1β-induced oxidative stress and relieve inflammation associated with IDD pathology. The gene discussed is IL1B; the disease is intervertebral disk degenerative disorder.